Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Clearance Process May Thwart 2010 Monograph Goal – ONP’s Ganley

This article was originally published in The Rose Sheet

Executive Summary

The Office of Nonprescription Products' goal of completing all OTC monographs by 2010 is viable only if FDA can improve its document-clearance process, according to ONP head Charles Ganley, MD

You may also be interested in...



Acting Commissioner Von Eschenbach Made Permanent In Time For New Year

Andrew von Eschenbach can delete "acting" from his office nameplate; the Senate confirmed him as FDA commissioner Dec. 7 by a comfortable 80-11 margin, ending months of "holds" on the vote and opposition to his nomination from both sides of the aisle

Acting Commissioner Von Eschenbach Made Permanent In Time For New Year

Andrew von Eschenbach can delete "acting" from his office nameplate; the Senate confirmed him as FDA commissioner Dec. 7 by a comfortable 80-11 margin, ending months of "holds" on the vote and opposition to his nomination from both sides of the aisle

FDA Clearance Of OTC Final Rules Targeted For 2010 – ONP

The Office of Nonprescription Products is aiming to wrap up pending over-the-counter final monographs by 2010, according to FDA officials

UsernamePublicRestriction

Register

LL055695

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel